Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Germany’s Merck Opens R&D Center In India
by Jean-François Tremblay
January 10, 2011
| A version of this story appeared in
Volume 89, Issue 2
Merck KGaA has inaugurated an R&D center in Mumbai. Occupying 1,700 m2, the center will provide application development support for the entire Merck product range, “from drug discovery to automobile and decorative paints.” The center will incorporate technical capabilities stemming from its acquisition of Millipore last year, the firm adds. Separately, Merck has acquired Beijing Skywing Technology, a supplier of cell-culture media products and bioreactors for the Chinese biopharmaceutical industry. The purchase, for about $18 million, strengthens the former Millipore business in China, Merck says.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter